Surrozen is discovering and developing new drug candidates to treat injury and disease by targeting the Wnt pathway. The Wnt pathway plays a critical role in development processes, stem cell maintenance and tissue regeneration. Combining their understanding of the Wnt pathway with advanced antibody engineering strategies, Surrozen is designing tissue-specific antibodies that engage the body’s own biological repair mechanisms to regenerate tissue. With pharmaceutical properties, Surrozen’s platform has the potential to overcome many of the current limitations of regenerative medicines.

Surrozen

Drug notes:

About:

Jobs: